Ascendis Pharma A/S Board of Directors

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Mr. Jan Moller Mikkelsen

Mr. Jan Moller Mikkelsen

President, CEO, Member of Executive Board & Executive Director

Dr. Kennett Sprogoe Ph.D.

Dr. Kennett Sprogoe Ph.D.

Executive VP and Head of Research & Product Development

Mr. Michael Wolff Jensen L.L.M.

Mr. Michael Wolff Jensen L.L.M.

Executive VP, Chief Legal Officer & Member of the Executive Board

Mr. Scott T. Smith

Mr. Scott T. Smith

CFO, Executive VP & Member of Executive Board

Mr. Timothy J. Lee

Mr. Timothy J. Lee

Senior Director of Investor Relations

Mr. Joseph Kelly

Mr. Joseph Kelly

Head of U.S. Commercial of Endocrinology

Ms. Lotte Sonderbjerg

Ms. Lotte Sonderbjerg

Executive VP, Chief Administrative Officer & Member of the Executive Board

Dr. Stina Singel M.D., Ph.D.

Dr. Stina Singel M.D., Ph.D.

Executive VP & Head of Clinical Development for Oncology

Mr. Flemming Steen Jensen

Mr. Flemming Steen Jensen

Executive Vice President of Product Supply & Quality

Mr. Mads Bodenhoff

Mr. Mads Bodenhoff

Senior VP of Finance & Principal Accounting Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.